Categories AlphaGraphs, Consumer, Earnings, Health Care

Johnson & Johnson (JNJ) reports Q1 2022 earnings

Johnson & Johnson (NYSE: JNJ) reported first-quarter 2022 financial results before the regular market hours on Tuesday.

The pharmaceutical giant reported revenue of $23.4 billion, up 5% year-over-year, with operational growth of 7.7%

Net earnings of $5.1 billion or $1.93 per share decreased by 17%, compared to the previous year.

  • johnson & Johnson Q2 2021 earnings

Most Popular

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) is an online pharmaceutical marketplace that provides a platform for independent pharmacies to operate more effectively. The company’s digital platform helps optimize drug procurement and

AMAT Stock: Is now the right time to invest in Applied Materials?

It is estimated that the size of the global chip manufacturing equipment market would nearly double from the current levels to about $142 billion in the next eight years. Applied

Here’s a look at Take-Two Interactive Software’s (TTWO) expectations for the coming year

Shares of Take-Two Interactive Software (NASDAQ: TTWO) were down over 2% on Friday. The stock has dropped 32% year-to-date and 35% over the past 12 months. Earlier this week, the

Add Comment
Viewing Highlight